5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

A number of pharmacogenetic studies have been carried out in non-small-cell lung cancer (NSCLC) to identify and characterize genes involved in chemotherapy activity. However, the results obtained so far are controversial and no reliable biomarker is currently used to predict clinical benefit from pl...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Toffalorio, Francesca, Santarpia, Mariacarmela, Radice, Davide, Jaramillo, Christopher Adrian, Spitaleri, Gianluca, Manzotti, Michela, Catania, Chiara, Jordheim, Lars Petter, Pelosi, Giuseppe, Peters, Godefridus J., Tibaldi, Carmelo, Funel, Niccola, Spaggiari, Lorenzo, de Braud, Filippo, De Pas, Tommaso, Giovannetti, Elisa
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2018
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893252/
https://ncbi.nlm.nih.gov/pubmed/29662657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24505
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg